MAT2A and hepatocellular carcinoma: Nuclear binding of NF-kappa B and AP-1 to the MAT2A promoter are increased in HCC, and tumor necrosis factor alpha (TNFα), which activates both sites, can increase MAT2A expression in a dose- and time-dependent manner [37].